RNAi therapeutic for liver fibrosis (Silence Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameRNAi therapeutic for liver fibrosis (Silence Therapeutics)

Drug Alias NameN/A

ClassificationSmall molecules > LipidSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionRNA interference

TargetsUpdating

Therapy Area/IndicationsLiver Cirrhosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSilence Therapeutics Plc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSilence Therapeutics Plc

Active IndicationsN/A

Inactive IndicationsLiver Cirrhosis

Other Information

ATC CodeN/A